In a separate study credentialing the Pax3::Foxo1 mouse model, induction of Pax3::Foxo1 expression in mice along with mutations in Ink4a/ARF (or CDKN2A) or Trp53 resulted in increased tumor penetrance. This evidence concerns the gene CDKN2A and neoplasm.